chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse affects noted. 19 year old patient received Adult dose of Hep B instead of the Pediatric dose. Pt. verbalized no reaction to Hep B vaccination.
Eye puffiness; This is a spontaneous report from a non-contactable other healthcare professional. A 34-year-old female patient second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231; expiry date: unknown) intramuscular (arm right), on 08Jan2021 at 11:00, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient has no known allergies. The patient previously received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140) intramuscular (arm left), on 22Dec2020, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 08Jan2021 at 13:00, the patient experienced eye puffiness. It was unknown if the patient received treatment for the event. Outcome of the event was recovering. The patient has not been tested for COVID-19 since vaccination.  No follow-up attempts are possible. No further information is expected.
pt recv vax 25MAR97 & 17JUN97 pt failed to seroconvert based on IgG titer of 0.47;
I had shingles years ago. Approximately two weeks after vaccine, I began having burning sensations in same area as shingles rash appeared previously. No rash, but some sensation to varying degrees every day on/off. Also mild on/off cold symptoms, low fever, lethargy. Continues to present.
Daptacel was inadvertently administered instead of Adacel to a 22-year-old patient; with no AE; vaccine was given to a 22 year old and it was supposed to be for the age group 6-8 weeks; with no AE; Initial information received on 23-Dec-2020 regarding an unsolicited valid non-serious case from a other health professional.  This case involves a 22 years old female patient who for whom it was reported that diphtheria-15/tetanus/5 ac pertussis vaccine [Daptacel] was inadvertently administered instead of Adacel (wrong product administered) and it was supposed to be for the age group 6-8 weeks (product use issue).   The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.   No concomitant medication was received.  On 22-Dec-2020, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE at a dose of 0.5 ml once (lot C5624AA and expiry date: 10-Jun-2021) via intramuscular route in the left deltoid for prophylaxis vaccination instead of Adacel (wrong product administered) and it was supposed to be for the age group 6-8 weeks (product use issue).  No laboratory data was provided.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was not applicable for the event.     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in directive 2001/83/ec and module VI of the good pharmacovigilance practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
low grade fevers; Their second dose of the vaccine is due tomorrow 04May2021 and they were told that they will be receiving the second dose on a different facility and have to reschedule; This is a spontaneous report from a Pfizer sponsored program and a contactable consumer (wife), who reported for her husband.  A 62-years-old male received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was Not reported) via an unspecified route of administration on 13Apr2021 as a DOSE 1, SINGLE dose for COVID-19 immunization.Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced low grade fevers and Their second dose of the vaccine is due tomorrow 04May2021 and they were told that they will be receiving the second dose on a different facility and have to reschedule. They both received their second Pfizer Covid vaccines on 05May2021 and on 06May2021 he reports they have low grade fevers. The reporter together with his wife, got their first dose of the vaccine 3 weeks ago (13Apr2021). Their second dose of the vaccine is due tomorrow 04May2021 and they were told that they will be receiving the second dose on a different facility and have to reschedule. He also wanted to know if it would matter if they can take it after their due date or if it will affect the vaccine. He had no questions at this time. The outcome of the events was unknown.  No unaddressed medical questions were referred or forwarded to Medical Information.  No follow-up attempts are needed. information about lot/batch number cannot be obtained.
Rash on neck/chest that spread to stomach as reported by patient. Lips swollen/red (anaphylaxis) 1-2 days later after receiving SHINGRIX vaccination (1st dose).
approximately 10 minutes after taking the covid vaccine client started c/o headache, tightness in her throat, and slight difficulty breathing. She self administered her albuterol inhaler, and was started on O2 AT 4 L.at 10:16 she said that the symptoms were all gone. at 10:24 she said her throat tightness had returned, she was offered benadryl and epinephrine which she refused bc she said she had to drive home. she took benadryl po when she got home.when she got home, the left side of her face became numb, she had a headache and burning eyes. The next day she still had a little numbness on the left side of her mouth. no problems since.
Patient started seizing after she received vaccine. Patient was unresponsive and shaking. Her skin was warm and clammy. After a few minutes, she was responsive and was able to answer questions when EMT arrived.
Tightness of chest the asthmatic attacks to this day (02/28/2014) @ home. Now wearing oxygen. Difficulty breathing and coughing.
At 09:30AM, patient sitting upright in chair. Tdap and MENACTRA given separately, intramuscularly in left deltoid, then GARDASIL 9 given intramuscularly in right deltoid. Immediately after injection in right deltoid, patient had syncopal episode with slouched posture in chair. Nurse (RN) and patient's mom assisted in maintaining and supporting patient in upright position in chair. Syncopal episode duration approximately less than 10 seconds. Patient spontaneously recovered with verbal complaints of right upper arm pain and headache. Diaphoresis and facial palor noted. Patient complained of dizziness and nausea. Patient remained seated for 15 minutes, apple juice offered. Patient's mom reported that he has not had anything to eat or drink this morning. After 15 minutes, patient states that nausea has resolved, improvement in diaphoresis and facial palor noted. Patient stood up with assistance, still complained of slight dizziness upon standing. Patient remained seated for 5 more minutes. After 5 minutes, diaphoresis and facial palor resolved. Patient stood up again with assistance, denies dizziness, but still has a slight headache. Patient observed while walking around office, gait steady. Vaccine information statements reviewed again with patient?s mom, patient?s mom made aware of signs and symptoms that require immediate medical attention. At approximately 9:50AM, patient and his mom exited building.
Pt received VZ #2 on 3/15/07 next day arm developed 2x3 cm erythema, induration and tenderness around vaccine site. no fever, able to move arm.
This initial case was missing the following minimal criteria: no identifiable patient. Upon receipt of follow up information on 06Oct2015, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable pharmacist via Pfizer sales representative. This pharmacist reported similar events for 7 patients. This is the 3rd of the 7 reports. An 80-year-old female patient (a retired ID Physician) of an unspecified ethnicity received PREVNAR 13 (Lot # J23867, Exp date 31Jan2016) intramuscular at 0.5 ml, single at left arm on 19Nov2014. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced rashes, chills, and pain on unspecified date with outcome of unknown. Two days after receiving vaccine on 21Nov2014 the patient experienced left arm cellulitis not requiring admission to the hospital. The patient was certain this was cellulitis, not a delayed vaccine reaction. The vial was tested for contaminant that comes back negative. The pharmacist considered there was a reasonable possibility that the event left arm cellulitis was related to the PREVNAR 13. Follow-up (02DEC2015): Follow-up attempts are completed. No further information is expected. Follow-up (14Dec2015): This is a follow up spontaneous report from a contactable Pharmacist included: patient occupation; suspect lot #, exp date and vaccination site; left arm cellulitis approximate onset date; patient assessment; pharmacist assessment.
Patient developed a rash up and down her left arm with raised arm bumps that were red in color. She used BENADRYL and hydrocortisone cream and they are going away.
DONOR STATED SHE HAD NAUSEA AND VOMITING 1 HR AFTER DONATING. DONOR ALSO STATED SHE DRANK APPLE CIDER VINEGAR WHEN SHE GOT HOME.
Had a serology and had a level of 3.9 but her other family members tested above 20.; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection and Lot Number: not provided), dose 1 via an unspecified route of administration on an unspecified date as single dose and dose 2 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history was not reported. Patient and her other family members did not have a history of COVID. The patient's concomitant medications were not reported. She got the double vaccine as well as the rest of her entire family. Her daughter went to camp and they required serology testing. All her family tested serology above 29 and her number came back at 3.9. She would like to know if she is not as covered as the rests of her family. When she got her vaccine, the rest of her family got pain in their arm and she had no reactions whatsoever. Her husband just told her that her arm hurt a little after getting it. It was like a tetanus shot but nothing bad. Separate report completed for husband. On an unspecified date, the patient had a serology and had a level of 3.9 but her other family members tested above 20. (laboratory test abnormal). she knew that there are also people who are fully vaccinated and tested zero on their antibodies test. The patient underwent lab tests and procedures which included serology test: 3.9 (Serology test came back at 3.9). Outcome of event was unknown.  Information on lot /batch number has been requested.
I am a physician. I received 2 doses of the pfizer vaccine, last in mid January. More than 4 weeks after, I am symptomatic and test positive for COVID
moderna 2nd dose received 2/16/21; 2/17/21 pt woke up with  left arm sore, cannot raise above head, fever 100.9, body aches, headache
Weak feeling, light headed, dizzy, lathargic, slight stomach ache, no appetite , ears ring, tenitis, body hurts. very high blood pressure with  no fever. This feeling got so bad that I went to the emergency room. Spent 7 hours and was released  with some counter meds for pain, nausea, and muscle spasm,  still feel this a little bit going into day 3.
I received my 1st vaccination on Friday, April 2nd. Minutes after receiving the vaccine, my throat started itching and feeling tight. I stayed for 30 minutes and the reaction never got any worse. Luckily, my airway was never blocked nor my breathing impaired. I went home, took 2 Benadryl, and about 2 hours later I went to bed and slept for 13 hours (approx). My throat was still a little tight that Saturday and my left arm was really sore, but by Sunday I felt completely normal.
I experienced they "typical" side effects of pain / aching at site of injection, chills, and muscle aches.  No problem.  What alarmed me was that  I also had greatly increased neuropathic pain.  I have chronic headaches due to cervical spine damage but these headaches were greatly magnified.  All my "usual" areas of pain due to existing injuries, mostly neuropathic, were greatly magnified.  Extreme low back pain started, so painful it hurt to lay on my back. The trip to get vaccinated wasn't long enough to trigger such extreme pain. I hardly slept due to the discomfort and extreme pain.  I experienced transient, strange pain, such as suddenly getting very sharp, stabbing pain in one toe on my right foot that lasted for about one (1) minute.  Same strange sudden sharp pain in my left knee while laying down, even though no known problems with that knee. I am physically fit. Very health conscious. A vegan.  This was easily one of the most total body painful experiences I have ever had.   It reminded me of one time I had a terrible bout of food poisoning, but with horrible nerve pain and without intestinal problems. I started taking Ibuprofen 800mg  the next morning and slept the rest of the day and night - since I got maybe 3 hours of interrupted sleep the night of the 2nd shot.  The day after that I was not 100% but much improved.  By the 3rd day post 2nd shot I felt normal.   Two other women in my social circle experienced similar reactions to the 2nd dose.   I read that more people with neuropathic and/or arthritic conditions are reporting similar reactions, and those with auto-immune conditions.  I would still get the vaccine - I would just have prepared better (doctor approved sleeping pills and pain medications.)
The pt developed cellulitis on left leg post immunization. Treated with Augmentin, warm compresses and Tylenol/Motrin for pain.
Fever and achiness at 6 hours after vaccine.  Headache now at 48 hour mark. Headache will not subside despite multiple doses of Tylenol
Rabies vaccine- human immoglobin and rabies vaccine series.  First week had fever, felt like body sunburn, tongue started prickly, flu ish, achiness.  2nd week sunburn feeling over body, prickly tongue, slight fever, soreness/pain, and arm heaviness.  3rd shot day after third shot got really fatigued during day and felt like needed to sleep, so took daytime nap and had body jerks, unable to get self up but half awake and biting tongue/like humming, then was really tired when got out of it and headache; week 3 body felt like sunburn, achy, prickly tongue, fatigue, right arm joints sore, rash on right side of stomach; and week 4 last shot within hour after shot right cheek swelling, rash on arms, itchy, lips numb swelling on right side, tongue prickly and felt right side swelling throat; later evening difficulty swallowing, diarrhea and same symptoms.  Since vaccinations I continue to have prickly tongue, fatigue, headaches, itchiness on arm and right cheek, swelling on right cheek and tongue issues like biting tongue while eating. I take 24hr Claritin or Zyrtec every 12 hrs because otherwise my cheek starts to swell and get itchy, and my tongue feels prickly.
Client complained of dizziness, hot.  States that she had drank ETOH and did not eat breakfast.  VSS 138/90 in right arm sitting.  Encouraged to drink water and she consumed some snacks.  Fanned with file to help cooling off process.  After 30 minutes, dizziness and hot feeling dissipated.  Encouraged to drink more fluids through the day.  Reviewed s/s of vaccine SEs.  Left unaccompanied on own after 30 minutes.
Vaccination was given per Temp staff past the beyond use date. The vaccine was stored in the fridge and should have been discarded after the 10 weeks at that temperature but was being administered based off of the expiration date instead which had not yet passed.
Developed weakness on lower extremities then swallowing difficult 1 month after 3rd HepB vac. Dx to have Guillain Barre by med center.
ADMINISTERED FLUCELVAX TO 12 YEAR OLD (FDA APPROVED TO OVER 18YO ONLY).
A 34-year-old patient with past medical history of nontraumatic compartment syndrome of lower extremity who reported to the Emergency Room with chief complaint of diffuse generalized pruritic rash and hives. Started 2 days ago 3 hours from getting the tetanus shot. He denied any shortness of breath, wheezing, difficulty swallowing, or other symptom. The patient was given SOLU-MEDROL 125 mg intravenously, BENADRYL 25 mg intravenously, ranitidine 50 mg intravenously, and 500 mL of normal saline. We will discharge him home on MEDROL Dosepak as directed. BENADRYL 125 mg every 6 hours if needed, and primary care provider for followup in 3 days if no improvement.
expired- 5 doses had been given at that point; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired- 5 doses had been given at that point) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2022 at 9:57 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 20-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired- 5 doses had been given at that point). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired- 5 doses had been given at that point) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.  Moderna vaccine pulled from freezer on 16 Dec 2021. BUD of 15 Jan 2022 printed in red and taped to the top of boxes. On 26 Jan 2022, staff brought it to the attention that it was still in the fridge and expired. On 31 Jan 2022, Moderna responded that re-vaccination not required.   Most recent FOLLOW-UP information incorporated above includes: On 24-Feb-2022: IRD updated.
Hot and cold chills; Hot and cold chills; Nose won't stop running; Keep getting nausea; Headache; the next week started getting sick; Hasn't felt good ever since.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administration date 15Apr2021 (Lot number: EW2161, Expiration Date: 31Jul2021) at the age of 58 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: CHILLS (non-serious), FEELING OF BODY TEMPERATURE CHANGE (non-serious) all with onset 20Apr2021, outcome "unknown" and all described as "Hot and cold chills"; RHINORRHOEA (non-serious) with onset 20Apr2021, outcome "unknown", described as "Nose won't stop running"; NAUSEA (non-serious) with onset 20Apr2021, outcome "unknown", described as "Keep getting nausea"; HEADACHE (non-serious) with onset 20Apr2021, outcome "unknown", described as "Headache"; FEELING ABNORMAL (non-serious) with onset 15Apr2021, outcome "unknown", described as "Hasn't felt good ever since."; ILLNESS (non-serious) with onset 20Apr2021, outcome "unknown", described as "the next week started getting sick".  Additional information: Patient was calling in regard to the Pfizer Covid-19 vaccine. She received the Covid-19 vaccine on 15Apr2021 and hasn't felt good ever since and reported that she is about to go to the emergency room. She reported that she has been experiencing hot and cold chills, her nose won't stop running, she keeps getting nausea, and a headache keeps coming to her head. Patient stated that at 1:00 on 28Apr2021, she was expecting a doctor to call and reported that it was an important call from her grandson who is a psychiatrist. She reported that she was going to the emergency room in a few minutes. She reported that she received the Covid-19 vaccine on 15Apr2021 and the next week started getting sick on Tuesday, 20Apr2021. She declined to provide an email address or alternate phone number. She reported that her physician is at (withheld) she reported that she was unable to provide her physician's zip code, phone number, or email address. She needed to end the phone call because she needed to go to the emergency room. She unable to provide NDC number of Covid-19 vaccine as it was not listed in her vaccination paperwork.  No follow-up attempts are possible. No further information is expected.
rash (all his right side of the body); This spontaneous case was reported by an other health care professional and describes the occurrence of RASH (rash (all his right side of the body)) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 04-Mar-2021, the patient experienced RASH (rash (all his right side of the body)). At the time of the report, RASH (rash (all his right side of the body)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant information  provided. No Treatment information  provided
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 23-JAn-2015, the patient was vaccinated with improperly stored VAQTA (strength: 25/0 (unit  unspecified), lot # K005323 with expiration date of 10-FEB-2017; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received on 04-MAY-2017 from a medical assistant regarding an unspecified number of unspecified patients of unknown ages and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, an unspecified number of unspecified patients were inadvertently administered 4 doses of LIQUID PEDVAXHIB (lot numbers and expiration dates not reported), intramuscular for prophylaxis.  The medical assistant reported that for "more than 3 years", her office has routinely been administering doses of LIQUID PEDVAXHIB to patients at 2 months, 4 months, 6 months and at 9 or 12 months of age. No adverse effect reported. No further information was provided.  Additional information has been requested.
This spontaneous report as received from a nurse refers to a patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX for prophylaxis reconstituted with properly stored sterile diluent (STERILE DILUENT). No adverse effects were reported. Data logger was involved. This is one of two reports received from the same reporter. Additional information is not expected.; Sender's Comments: US-009507513-1707USA009253:
Weakness, fatigue started that night.  Generalized allergic/viral type rash started with high fever the next morning. Also complained of hand/feet swelling, hives. Pt seen in UC with 102 fever (2hrs after taking 400mg of ibuprofen).